General Information
Revision date
2004-12-16
Product name
March 8, 2001
Substance name
March 8, 2001
1.2.1 Relevant identified uses
Body Filler Thinner
Manufacturer Name
Bondo Corporation
Icons in SDS
Company Information
company name
Bondo Corporation
Section 2
Hazardous Ingredients
OSHA Percent Vapor ACGIH weight CAS No. Press. TLV PEL Oral Derm Inhal LEL Styrene 35% 100-42-5 4.5 20ppm 100ppm 2650 n. av. 12000 1.1 LD50 Oral - rat mg/m3, LD50 Dermal - rabbit mg/m3,LC50 Inhalation - rat mg/m3 unless otherwise specified. Section 3 – Hazards Identification Primary Routes of Entry: Inhalation, skin contact, ingestion, eyes. Exposure Effects Acute and Chronic: Inhalation Acute Nasal and respiratory irritation, nausea, cough, shortness of breath, dehydration, allergic respiratory reaction, tiredness, dizziness, weakness, headache, anesthesia, drowsiness, fatigue, chest pain, vomiting, central nervous system effects, narcosis. Liquid can be fatal if aspirated into the lungs. Skin contact Acute Extraction of natural oils with resulting dry skin, irritation, allergic skin reactions, redness and dermatitis. May be absorbed through the skin. Eye contact Acute Irritation, redness, pain, tearing, blurred vision, sensation of seeing halos around lights and reversible damage. Ingestion Acute Gastrointestinal irritation, nausea, vomiting, diarrhea, weakness, headache, dizziness, drowsiness, fatigue, lack of coordination, central nervous system effects, depression. Chronic Repeated overexposure to this product may cause central nervous system damage, hearing damage, kidney damage, liver abnormalities, lung damage, cardiac abnormalities, reproductive organ damage, blood effects, eye damage. Other Health Effects: Intentional misuse by deliberately concentrating and inhaling the contents may be harmful or fatal. Reports have associated repeated and prolonged occupational overexposure to solvents with permanent brain and nervous system damage.